Medication info
Rivaroxaban High Tablet 4/160/5 mg (Pitavastatin Calcium Hydrate, Valsartan, Amlodipine Besylate)

Rivaroxaban High Tablet 4/160/5 mg (Pitavastatin Calcium Hydrate, Valsartan, Amlodipine Besylate)

Prescription medicationTabletOral
Ingredient · strength
Valsartan›160mg / 1 tabletAmlodipine Besylate›6.94mg / 1 tabletPitavastatin Calcium Hydrate›4.409mg / 1 tablet
Manufacturer / importer
JW Pharmaceutical Corp.
Appearance
Oval film-coated tablet of deep yellow color
Packaging
30 tablets/PPT [6 tablets/PPT x 5]
Approval status
Active

MFDS item code 202502534 · Approved 2025.09.24 · Insurance code 644915440

Summary

Main use
Treatment of primary hypercholesterolemia, mixed dyslipidemia, and essential hypertension
Who takes it
Adults
Adult dose
Take 1 tablet once daily with water. It is recommended that the medicine be taken at the same time each day, if possible (e.g., before breakfast). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and pitavastatin. Patients taking the amlodipine/valsartan combination and pitavastatin as separate medicines may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. ▷ Amlodipine/valsartan combination It is recommended that the dose of each individual component (amlodipine or valsartan) be adjusted before administering the amlodipine/valsartan combination. However, a direct switch to the amlodipine/valsartan combination may be considered if blood pressure is not controlled with monotherapy using either component, as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients with renal impairment: No dosage adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 10mL/min or greater). Do not administer the amlodipine/valsartan combination to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, the daily dose of valsartan must not exceed 80mg. Do not administer the amlodipine/valsartan combination to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years and older: Use caution when increasing the dose. ▷ Pitavastatin Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose for adults is 1~2 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is inadequate, the dose may be increased to a maximum of 4 mg daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient's response. The therapeutic effect of this medicine is maintained with continued administration.

Ingredients

Manufacturer
JW Pharmaceutical Corp.

Efficacy & effects

Treatment of primary hypercholesterolemia, mixed dyslipidemia, and essential hypertension

  • Essential hypertension
  • primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated Apo-B protein
  • elevated triglycerides
View approved original text

This medicine is used for patients with essential hypertension who cannot control blood pressure with Amlodipine and Valsartan alone, and at the same time, Pitavastatin helps improve cholesterol levels in patients with primary hypercholesterolemia or mixed dyslipidemia. In other words, it is a suitable treatment method for patients who need to manage both blood pressure and blood lipid levels. This combined management effectively controls blood pressure and cholesterol levels, improving cardiovascular health.

How to take

Adult dose

Take 1 tablet once daily with water. It is recommended that the medicine be taken at the same time each day, if possible (e.g., before breakfast). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and pitavastatin. Patients taking the amlodipine/valsartan combination and pitavastatin as separate medicines may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. ▷ Amlodipine/valsartan combination It is recommended that the dose of each individual component (amlodipine or valsartan) be adjusted before administering the amlodipine/valsartan combination. However, a direct switch to the amlodipine/valsartan combination may be considered if blood pressure is not controlled with monotherapy using either component, as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients with renal impairment: No dosage adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 10mL/min or greater). Do not administer the amlodipine/valsartan combination to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, the daily dose of valsartan must not exceed 80mg. Do not administer the amlodipine/valsartan combination to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years and older: Use caution when increasing the dose. ▷ Pitavastatin Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose for adults is 1~2 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is inadequate, the dose may be increased to a maximum of 4 mg daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient's response. The therapeutic effect of this medicine is maintained with continued administration.

Precautions

This medicine can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it must be discontinued immediately upon confirmation of pregnancy. Patients with hypersensitivity to the ingredients of this medicine or with severe liver or kidney disorders, as well as pregnant or breastfeeding women, should not take this medication. Patients with sodium or fluid depletion, those with hyperkalemia, and patients with renal artery stenosis should use this drug with caution and monitor blood pressure and kidney function closely. In patients with heart disease, such as heart failure or post-myocardial infarction, or aortic valve stenosis patients, this medication should also be administered with caution. During medication, adverse effects such as blood pressure drop, edema, headache, itching, gastrointestinal disturbances, myalgia, and others may occur, so if these symptoms are severe or persistent, consult a doctor. Caution is needed when driving or operating machinery as dizziness or fatigue may occur. This medicine may interact with other drugs, so particular caution is needed when used with cyclosporine, fibrate medications, niacin, certain antibiotics, and drugs that increase potassium levels. Pregnant or breastfeeding women should not take this medication, and if pregnancy is confirmed during the course of treatment, it must be discontinued immediately. The safety for pediatric patients or those under 18 years of age has not been established, so it is advisable not to use it in this age group. Elderly patients may react more sensitively to the medication, so starting at a lower dose and gradually increasing is recommended. In case of overdose, severe hypotension or shock may occur; therefore, immediate medical attention is required.

Side effects

COVID-19, nasopharyngitis, systemic edema, peripheral edema, increased serum creatine phosphokinase activity, headache, itching, sudden hearing loss, intestinal obstruction, diplopia, thrombocytopenia, leukopenia, allergic reactions, hyperglycemia, insomnia, mood changes, tremors, sensory impairment, taste disturbance, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, dysuria, nocturia, gynecomastia, pain, fatigue, chest pain, weight loss, weight gain, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, serum sickness, increased serum potassium, renal failure, kidney damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, intestinal vascular edema, abdominal pain, rash, paralysis, elevated γ-GT, increased plasma creatine phosphokinase levels, increased serum ALT, increased serum AST, rhabdomyolysis, myopathy, liver dysfunction, jaundice, hypersensitivity reactions, elevated bilirubin, increased cholinesterase, rigidity, drowsiness, heavy head, dizziness, thirst, abdominal distension, constipation, stomatitis, decreased appetite, glossitis, nausea, gastric discomfort, diarrhea, decreased granulocyte count, increased leukocytes, increased globulins, positive Coombs test, anemia, polyuria, increased BUN, decreased aldosterone, increased aldosterone, increased ACTH, increased cortisol, decreased testosterone, muscle cramps, increased serum myoglobin, muscle pain, weakness, palpitations, skin pain, burning sensation, arthralgia, edema, blurred vision, photophobia, hearing loss, hematuria, elevated uric acid levels, increased serum potassium and phosphorus, taste disturbance, colored urine, fatigue, positive ANA, alopecia, sleep disorders, memory loss, depression, interstitial lung disease, sexual dysfunction, immune-mediated necrotizing myopathy, facial edema, arm edema, hypersensitivity, skin paresthesia, elevated blood pressure, chest discomfort, asthenia, dizziness, skin paresthesia

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine should be stored at room temperature between 1 to 30 degrees Celsius, and it's important to keep it in a tightly sealed container to prevent air exposure. This helps preserve the drug's efficacy for a longer period.

Appearance and packaging

Appearance

Oval film-coated tablet of deep yellow color

Package unit

30 tablets/PPT [6 tablets/PPT x 5]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.